Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

PDL BioPharma Company Profile (NASDAQ:PDLI)

Consensus Ratings for PDL BioPharma (NASDAQ:PDLI) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $8.75 (31.38% upside)

Analysts' Ratings History for PDL BioPharma (NASDAQ:PDLI)
Show:
DateFirmActionRatingPrice TargetActions
4/30/2015TheStreetDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/19/2014ZacksUpgradeNeutral -> Outperform$9.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/20/2014ZacksReiterated RatingNeutral -> Neutral$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/20/2014Cowen and CompanyBoost Price Target$7.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2013 forward)